UCB reported EUR857M in Net Income for its fiscal semester ending in December of 2024.


Net Income Change Date
Alcon AG USD 176M 174M Jun/2025
Almirall EUR 26.58M 4.98M Jun/2025
Amarin USD -15697000 32.92M Mar/2025
argenx SE USD 245.36M 75.89M Jun/2025
AstraZeneca USD 2.45B 466M Jun/2025
Bayer EUR -199000000 1.5B Jun/2025
Galapagos EUR -105748000 47.66M Jun/2025
Genmab DKK 336M 141M Jun/2025
GlaxoSmithKline GBP 1.44B 181M Jun/2025
GRIFOLS EUR 117.06M 57.34M Jun/2025
Hikma Pharmaceutical USD 133M 93M Dec/2024
Lonza CHF 307M 22M Dec/2024
Merck EUR 652M 83M Jun/2025
Novartis USD 4.02B 418M Jun/2025
Orion EUR 82.5M 21.3M Jun/2025
Recordati EUR 91.08M 33.96M Jun/2025
Roche Holding CHF 1.01B 2.12B Dec/2024
Sanofi EUR 3.94B 2.07B Jun/2025
UCB EUR 857M 649M Dec/2024
Unibail Rodamco EUR 74.5M 38.65M Dec/2024